Business

APEC take: China's potential, region's growth

China Daily

Updated: 2026-11-19 10:12

Share - WeChat
A humanoid robot makes ice cream for visitors at a park in Shenzhen, south China's Guangdong Province, Aug. 3, 2026. Humanoid robots are being deployed across a wide spectrum of application scenarios in Shenzhen, becoming increasingly integrated into everyday work and life. [Photo/Xinhua]

Editor's Note: As APEC economies navigate a changing global economic landscape, the trend for open markets, technological innovation and closer business cooperation has never been stronger. China's continued opening-up, its drive to integrate artificial intelligence into the real economy, and its strengths in advanced manufacturing and green technologies are creating new opportunities for businesses across the Asia-Pacific region. In this special Q&A, foreign business executives share their perspectives on how these developments can support productivity, accelerate the green transition and deepen regional economic ties. The broader opportunity lies not only in individual markets, but in building more resilient, innovative and sustainable growth across the region.

Sarath Prasannan Senior vice-president and head of region Asia Pacific at Everllence

Q1 China's continued opening-up is reshaping the business landscape. Where do you see the greatest opportunities for foreign firms in China and across APEC economies?

PRASANNAN: China's continued opening-up and 15th Five-Year Plan (2026-30) provide greater visibility for business planning, creating opportunities for industrial collaboration and investment across APEC. For Everllence, this gives rise to long-term, mutually beneficial partnerships built on shared innovation, local expertise and complementary capabilities.

Deep-rooted industrial partnerships boost the green transition. China boasts complete advanced manufacturing ecosystems, world-leading shipbuilding output, sizable retrofit capacity and fast-growing demand for net zero solutions. Everllence maintains long-standing partnerships with the main players in China, which reflects our long-term commitment to this market.

China's industrial scale and project-delivery capabilities provide a strong foundation for bringing advanced technologies into commercial applications, with valuable experience that can inform deployment across other APEC markets.

XIA: Asia is the fastest-growing region for the global chemical industry, and China is the world's largest chemicals producer. We see the greatest opportunities in sectors such as biotechnology, new energy, batteries and the circular economy, many of which have China at their center. With their complementary strengths in innovation, manufacturing, resources, talent and market demand, APEC economies are well positioned to capture these opportunities. China's continued opening-up enables multinational companies to connect these capabilities, innovate closer to customers, build more resilient regional supply networks and create sustainable growth across the region.

ZHENG: The greatest opportunity lies in connecting China's innovation ecosystem with global drug development: helping Chinese innovators develop medicines for international markets while enabling multinational companies to address patient needs in China and across APEC. Home to 3 billion people, the region offers considerable scope to translate scientific advances into medicines that benefit more patients.

The region combines innovation capacity with complementary research strengths. China accounts for about 30 percent of the global drug development pipeline, underscoring its growing importance as a global pharmaceutical innovation hub. Alongside the innovative drug research and development capabilities shared by China, the United States, Japan and South Korea, US discovery and translational science, Japan's pharmaceutical and specialist expertise, and Australia's early-phase capabilities offer opportunities for collaboration. Clinical research capabilities and continued digital investment provide a foundation for this cooperation. Greater openness and regulatory dialogue can help connect these strengths while respecting local requirements.

Parexel serves as a strategic bridge between these ecosystems. Our network spans the Americas, Europe and Asia-Pacific, with capabilities covering Phase I through Phase IV clinical development, regulatory strategy and market access. In 2025, our projects involved more than 42,000 research sites and 24,000 investigators across more than 70 countries and regions.

SHIH: We believe the greatest opportunities lie in the mutually reinforcing development of China's manufacturing sector and business cooperation across the Asia-Pacific region. China's comprehensive manufacturing ecosystem, diverse industrial applications and demand for industrial AI, operational efficiency and green transformation create significant opportunities for multinational companies to connect global resources with local needs and deepen partnerships.

Rockwell Automation aims to draw on its horizontal integration capabilities as an industrial chain leader in the producer services sector, bringing together core technologies, operational excellence and a cross-sector ecosystem. We seek to connect technological capabilities with industrial needs and support the deployment of innovations at scale, helping innovation deliver tangible value to the real economy.

Across Asia-Pacific, we will combine global capabilities with local adaptation to support companies' overseas deployment and multisite operations, while facilitating the exchange and replication of proven practices across markets.

1 2 3 4 Next   >>|
Copyright 1994 -

Registration Number: 130349

Mobile